Literature DB >> 33229340

Glutamine-Directed Migration of Cancer-Activated Fibroblasts Facilitates Epithelial Tumor Invasion.

Aida Mestre-Farrera1, Marina Bruch-Oms1, Raúl Peña1, José Rodríguez-Morató2,3,4, Lorena Alba-Castellón1, Laura Comerma5, Miguel Quintela-Fandino6, Mireia Duñach7, Josep Baulida1, Óscar J Pozo2, Antonio García de Herreros8,3.   

Abstract

Tumors are complex tissues composed of transformed epithelial cells as well as cancer-activated fibroblasts (CAF) that facilitate epithelial tumor cell invasion. We show here that CAFs and other mesenchymal cells rely much more on glutamine than epithelial tumor cells; consequently, they are more sensitive to inhibition of glutaminase. Glutamine dependence drove CAF migration toward this amino acid when cultured in low glutamine conditions. CAFs also invaded a Matrigel matrix following a glutamine concentration gradient and enhanced the invasion of tumor cells when both cells were cocultured. Accordingly, glutamine directed invasion of xenografted tumors in immunocompromised mice. Stimulation of glutamine-driven epithelial tumor invasion by fibroblasts required previous CAF activation, which involved the TGFβ/Snail1 signaling axis. CAFs moving toward Gln presented a polarized Akt2 distribution that was modulated by the Gln-dependent activity of TRAF6 and p62 in the migrating front, and depletion of these proteins prevented Akt2 polarization and Gln-driven CAF invasion. Our results demonstrate that glutamine deprivation promotes CAF migration and invasion, which in turn facilitates the movement of tumor epithelial cells toward nutrient-rich territories. These results provide a novel molecular mechanism for how metabolic stress enhances invasion and metastasis. SIGNIFICANCE: Cancer-associated fibroblasts migrate and invade toward free glutamine and facilitate invasion of tumor epithelial cells, accounting for their movement away from the hostile conditions of the tumor towards nutrient-rich adjacent tissues. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/81/2/438/F1.large.jpg. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33229340     DOI: 10.1158/0008-5472.CAN-20-0622

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Reprogramming of cancer-associated fibroblasts by apoptotic cancer cells inhibits lung metastasis via Notch1-WISP-1 signaling.

Authors:  Hee Ja Kim; Kyungwon Yang; Kiyoon Kim; Ye-Ji Lee; Sieun Lee; Sung Yong Ahn; Young-Ho Ahn; Jihee Lee Kang
Journal:  Cell Mol Immunol       Date:  2022-10-14       Impact factor: 22.096

Review 2.  Mapping the Metabolic Networks of Tumor Cells and Cancer-Associated Fibroblasts.

Authors:  Jessica Karta; Ysaline Bossicard; Konstantinos Kotzamanis; Helmut Dolznig; Elisabeth Letellier
Journal:  Cells       Date:  2021-02-02       Impact factor: 6.600

Review 3.  Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment.

Authors:  Lisha Bao; Tong Xu; Xixuan Lu; Ping Huang; Zongfu Pan; Minghua Ge
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

Review 4.  Modeling the Role of Cancer-Associated Fibroblasts in Tumor Cell Invasion.

Authors:  Stephanie Poon; Laurie E Ailles
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

Review 5.  New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment.

Authors:  Ji-Yong Sung; Jae-Ho Cheong
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600

6.  Glutamine deficiency promotes recurrence and metastasis in colorectal cancer through enhancing epithelial-mesenchymal transition.

Authors:  Hongyan Sun; Chuan Zhang; Yang Zheng; Chenlu Liu; Xue Wang; Xianling Cong
Journal:  J Transl Med       Date:  2022-07-22       Impact factor: 8.440

Review 7.  Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.

Authors:  Yifei Zhu; Xinyan Li; Lei Wang; Xiwei Hong; Jie Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-15       Impact factor: 6.055

Review 8.  TGF-β signaling in the tumor metabolic microenvironment and targeted therapies.

Authors:  Xueke Shi; Jin Yang; Shuzhi Deng; Hongdan Xu; Deyang Wu; Qingxiang Zeng; Shimeng Wang; Tao Hu; Fanglong Wu; Hongmei Zhou
Journal:  J Hematol Oncol       Date:  2022-09-17       Impact factor: 23.168

Review 9.  Metabolic Drivers of Invasion in Glioblastoma.

Authors:  Joseph H Garcia; Saket Jain; Manish K Aghi
Journal:  Front Cell Dev Biol       Date:  2021-07-01

Review 10.  Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.

Authors:  Zhenzhen Li; Chanjun Sun; Zhihai Qin
Journal:  Theranostics       Date:  2021-07-13       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.